𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomized, prospective trial of adjuvant chemotherapy in adults with soft tissue sarcomas of the head and neck, breast, and trunk

✍ Scribed by Jerry Glenn; Timothy Kinsella; Eli Glatstein; Joel Tepper; Alan Baker; Paul Sugarbaker; William Sindelar; Jack Roth; Murray Brennan; Jose Costa; Claudia Seipp; Robert Wesley; Robert C. Young; Steven A. Rosenberg


Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
763 KB
Volume
55
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Soft-tissue sarcomas of the head and nec
✍ Marco T. A. Figueiredo; Lourdes A. Marques; Nelson Campos-Filho πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 French βš– 273 KB πŸ‘ 1 views

Ninety-four soft-tissue sarcomas of head and neck occurring among 10,700 malignancies, seen during the period 1953-I980 in the head-and-neck surgical department, were studied with reference to age, sex, ethnic origin, site, histological type and survival. The objective was to review our own experien

The cognitive sequelae of standard-dose
✍ Jeffrey S. Wefel; Renato Lenzi; Richard L. Theriault; Robert N. Davis; Christina πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 112 KB

## Abstract ## BACKGROUND Retrospective trials have reported that chemotherapy‐induced cognitive dysfunction was experienced by a subset of patients with breast carcinoma. However, recent evidence indicated that a subset also exhibited impaired cognitive function at baseline, before the start of c

A prospective phase ii trial of concomit
✍ Louis B. Harrison; Adam Raben; David G. Pfister; Michael Zelefsky; Elliot Strong πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 104 KB πŸ‘ 2 views

Background. Our study is a prospective evaluation of unresectable malignant cancers of the head and neck treated with concomitant chemotherapy and radiotherapy (RT) using delayed accelerated fractionation (concomitant boost). Methods: Between January 1988 and March 1995, 82 patients with unresectab